Erratum to: Identification of mutations, gene expression changes and fusion transcripts by whole transcriptome RNAseq in docetaxel resistant prostate cancer cells

Ma et al. SpringerPlus (2016) 5:2084 DOI 10.1186/s40064-016-3759-z Open Access ERRATUM Erratum to: Identification of mutations, gene expression changes and fusion transcripts by whole transcriptome RNAseq in docetaxel resistant prostate cancer cells Yuanjun Ma1, Yali Miao1,2, Zhuochun Peng1, Johanna Sandgren1, Teresita Díaz De Ståhl1, Mikael Huss3, Lena Lennartsson1, Yanling Liu1, Monica Nistér1,4, Sten Nilsson1,5 and Chunde Li1,5* Erratum to: SpringerPlus (2016) 5:1861 DOI 10.1186/s40064‑016‑3543‑0 After the publication of our article (Ma et al. 2016), we became aware of an error in the “Fusion transcript detection and validation” section of our Results. “Two gene fusions had been found by previous studies: UBE2L3-KRAS (Wang et al. 2011) expressed in all three cell lines and TAF15-AP2B1 (http://54.84.12.177/PanCanFusV2/Fusions!fusion) specific expressed in Du145 (Additional file 3). The other fourteen fusions were novel discovered.” Should read: “Two gene fusions had been found in prostate cancer in previous studies (Wang et al. 2011; Klijn et al. 2015): UBE2L3-KRAS and C14orf166-SLC25A21 were expressed in all three cell lines in our study (Additional file 3). The other fourteen fusions are reported here for the first time in prostate cancer.” The online version of the original article can be found under doi:10.1186/s40064-016-3543-0. Received: 28 November 2016 Accepted: 28 November 2016 References Klijn C, Durinck S, Stawiski EW, Haverty PM, Jiang Z, Liu H et al (2015) A comprehensive transcriptional portrait of human cancer cell lines. Nat Biotechnol 33:306–312 Ma Y, Miao Y, Peng Z, Sandgren J, Díaz De Ståhl T, Huss M, Lennartsson L, Liu Y, Nistér M, Nilsson S, Li C (2016) Identification of mutations, gene expres‑ sion changes and fusion transcripts by whole transcriptome RNAseq in docetaxel resistant prostate cancer cells. SpringerPlus 5:1861 Author details 1 Department of Oncology‑Pathology, Karolinska Institutet, Stockholm, Swe‑ den. 2 Department of Obstetrics and Gynecology, Beijing University People’s Hospital, Beijing, China. 3 SciLifeLab (Science for Life Laboratory), Stockholm, Sweden. 4 Clinical Pathology/Cytology, Karolinska University Hospital, Stockholm, Sweden. 5 Department of Clinical Oncology, Karolinska University Hospital, Stockholm, Sweden. *Correspondence: 1 Department of Oncology‑Pathology, Karolinska Institutet, Stockholm, Sweden Full list of author information is available at the end of the article © The Author(s) 2016. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.  (...truncated)